SALPINI, ROMINA

SALPINI, ROMINA  

Dipartimento di Biologia  

Mostra records
Risultati 1 - 20 di 117 (tempo di esecuzione: 0.024 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2015 A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. Aragri, M; Coppola, N; Alteri, C; Battisti, A; Sagnelli, C; Pisaturo, M; Bellocchi, M; Salpini, R; Starace, M; Armenia, D; Carioti, L; Pollicita, M; Sagnelli, E; Perno, C; Svicher, V Intervento a convegno
23-feb-2020 A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro Salpini, R; Piermatteo, L; Battisti, A; Colagrossi, L; Aragri, M; Yu La Rosa, K; Bertoli, A; Saccomandi, P; Lichtner, M; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Iapadre, N; Cerva, C; Aquaro, S; Angelico, M; Sarmati, L; Andreoni, M; Verheyen, J; Ceccherini-Silberstein, F; Levrero, M; Perno, Cf; Belloni, L; Svicher, V Articolo su rivista
1-gen-2015 A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy Pollicita, M; Alteri, C; Bellocchi, M; Armenia, D; Carioti, L; Salpini, R; Colagrossi, L; Battisti, A; Aragri, M; Fabeni, L; Mariani, R; Dalessandro, M; Ranelli, A; Paoloni, M; Parruti, G; Perno, Cf; Svicher, V Articolo su rivista
26-lug-2019 A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection Salpini, R; Battisti, A; Colagrossi, L; Di Carlo, D; Fabeni, L; Piermatteo, L; Cerva, C; Lichtner, M; Mastroianni, C; Marignani, M; Maylin, S; Delaugerre, C; Morisco, F; Coppola, N; Marrone, A; Angelico, M; Sarmati, L; Andreoni, M; Perno, C-; Ceccherini-Silberstein, F; Svicher, V Articolo su rivista
1-gen-2022 Acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer, hampers HBsAg stability and secretion and promotes cell survival Piermatteo, L; Carioti, L; Leoni, G; Duca, L; Saccomandi, P; Stella, D; Andreassi, E; Bertoli, A; Cappiello, G; Fleury, H; Svicher, V; Salpini, R Articolo su rivista
1-gen-2023 Amino acid variability of small molecule inhibitors and mAbs target sites in globally circulating RSV strains Fox, V; Scutari, R; Salpini, R; La Frazia, S; Bandera, A; Priralla, A; Periani, E; Gori, A; Svicher, V; Alteri, C Intervento a convegno
1-gen-2022 An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. Bellocchi, Mc; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; Ceccherini-Silberstein, F Intervento a convegno
2-apr-2021 An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression Brancaccio, G; Salpini, R; Piermatteo, L; Surdo, M; Fini, V; Colagrossi, L; Cantone, M; Battisti, A; Oda, Y; Di Carlo, D; Ceccherini-Silberstein, F; Perno, Cf; Gaeta, Gb; Svicher, V Articolo su rivista
22-giu-2013 Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen Cento, V; Van Hemert, F; Neumann Fraune, M; Mirabelli, C; Di Maio, V; Salpini, R; Bertoli, A; Micheli, V; Gubertini, G; Romano, S; Visca, M; De Sanctis, G; Berkhout, B; Marino, N; Mazzotta, F; Cappiello, G; Spanò, A; Sarrecchia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf; Svicher, V Articolo su rivista
10-mag-2019 Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy Fabeni, L; Alteri, C; Berno, G; Scutari, R; Orchi, N; De Carli, G; Bertoli, A; Carioti, L; Gori, C; Forbici, F; Salpini, R; Vergori, A; Gagliardini, R; Cicalini, S; Mondi, A; Pinnetti, C; Mazzuti, L; Turriziani, O; Colafigli, M; Borghi, V; Montella, F; Pennica, A; Lichtner, M; Girardi, E; Andreoni, M; Mussini, C; Antinori, A; Ceccherini-Silberstein, F; Perno, Cf; Santoro, Mm Articolo su rivista
1-gen-2012 Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon Ceccarelli, L; Salpini, R; Moudourou, S; Cento, V; Santoro, M; Fokam, J; Takou, D; Nanfack, A; Dori, L; Torimiro, J; Sarmati, L; Andreoni, M; Perno, Cf; Colizzi, V; Cappelli, G Articolo su rivista
1-gen-2011 Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. Salpini, R; Svicher, V; Cento, V; Gori, C; Bertoli, A; Scopelliti, F; Micheli, V; Cappiello, T; Spanò, A; Rizzardini, G; De Sanctis, G; Sarrecchia, C; Angelico, M; Perno, Cf Articolo su rivista
1-gen-2022 Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. Bellocchi, M; Carioti, L; Scutari, R; Iannetta, M; Piermatteo, L; Alkhatib, M; Tedde, S; Duca, L; Coppola, L; Malagnino, V; Crea, A; Ansaldo, L; D’Anna, S; Santoro, Mm; Bertoli, A; Di Lorenzo, A; Salpini, R; Svicher, V; Teti, E; Braccialarghe, N; Cavasio, Ra; Sarmati, L; Andreoni, M; Ceccherini-Silberstein., F Articolo su rivista
1-gen-2016 Combined analysis of the prevalence of drug-resistant Hepatitis B virus in antiviral therapy-experienced patients in Europe (CAPRE) Hermans, L; Svicher, V; Pas, S; Salpini, R; Alvarez, M; Ben Ari, Z; Boland, G; Bruzzone, B; Coppola, N; Seguin Devaux, C; Dyda, T; Garcia, F; Kaiser, R; Kose, S; Krarup, H; Lazarevic, I; Lunar, M; Maylin, S; Micheli, V; Mor, O; Paraschiv, S; Paraskevis, D; Poljak, M; Puchhammer Stockl, E; Simon, F; Stanojevic, M; Stene Johansen, K; Tihic, N; Trimoulet, P; Verheyen, J; Vince, A; Weis, N; Yalcinkaya, T; Lepej, S; Perno, Cf; Boucher, C; Wensing, A Articolo su rivista
1-gen-2012 Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02_AG) in Italy Santoro, M; Alteri, C; Ronga, L; Flandre, P; Fabeni, L; Mercurio, F; D'Arrigo, R; Gori, C; Palamara, G; Bertoli, A; Forbici, F; Salpini, R; Boumis, E; Tozzi, V; Visco Comandini, U; Zaccarelli, M; Van Houtte, M; Pattery, T; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf Articolo su rivista
8-dic-2021 Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection Borrajo, A; Svicher, V; Salpini, R; Pellegrino, M; Aquaro, S Articolo su rivista
1-gen-2020 Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers Salpini, R; Malagnino, V; Piermatteo, L; Mulas, T; Alkhatib, M; Scutari, R; Teti, E; Cerva, C; La Rosa, Ky; Brugneti, M; Bertoli, A; Rossi, B; Holzmayer, V; Gersch, J; Kuhns, M; Cloherty, G; Ceccherini-Silberstein, F; Perno, C-; Iannetta, M; Andreoni, M; Sarmati, L; Svicher, V Articolo su rivista
1-gen-2020 Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses Artese, A; Svicher, V; Costa, G; Salpini, R; Di Maio, Vc; Alkhatib, M; Ambrosio, Fa; Santoro, M; Assaraf, Yg; Alcaro, S; Ceccherini-Silberstein, F Articolo su rivista
1-gen-2020 Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses Artese, A; Svicher, V; Costa, G; Salpini, R; Di Maio, Vc; Alkhatib, M; Ambrosio, Fa; Santoro, M; Assaraf, Yg; Alcaro, S; Ceccherini Silberstein, F Articolo su rivista
1-gen-2013 Detecting hepatitis B viral amino acid sequence mutations in occult hepatitis B infections via bayesian partition model Lian, Z; Tian, Qn; Liu, Y; Cento, V; Salpini, R; Perno, Cf; Svicher, V; Chen, G; Li, C; Zhang, J Articolo su rivista